| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 202 | 29 | 0 | 4 | 4 | 0 | 1.764 | 20.053 | 67.805 | 103.216 |
| Total Income - EUR | 202 | 29 | 0 | 4 | 4 | 1.988 | 10.737 | 28.763 | 77.469 | 114.917 |
| Total Expenses - EUR | 879 | 909 | 0 | 0 | 0 | 2.014 | 12.544 | 34.307 | 81.692 | 120.375 |
| Gross Profit/Loss - EUR | -677 | -880 | 0 | 4 | 4 | -26 | -1.807 | -5.544 | -4.223 | -5.458 |
| Net Profit/Loss - EUR | -683 | -881 | 0 | 4 | 4 | -26 | -1.825 | -5.744 | -4.901 | -7.461 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Davimoridana Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 179 | 140 | 138 | 4 | 4 | 2.428 | 6.887 | 6.330 | 31.807 | 35.274 |
| Inventories | 108 | 107 | 105 | 0 | 0 | 0 | 2.401 | 0 | 19.893 | 18.820 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 1.861 | 0 | 0 | 9.605 | 8.142 |
| Cash | 71 | 34 | 33 | 4 | 4 | 568 | 4.486 | 6.330 | 2.309 | 8.312 |
| Shareholders Funds | -2.684 | -3.538 | -3.478 | 4 | 4 | 19 | -1.806 | -7.557 | -12.435 | -19.827 |
| Social Capital | 225 | 223 | 219 | 0 | 0 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.975 | 3.789 | 3.725 | 0 | 0 | 2.409 | 8.693 | 13.886 | 44.242 | 55.101 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1061 - 1061" | |||||||||
| CAEN Financial Year |
1061
|
|||||||||
Comments - Davimoridana Srl